-
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 DiabetesSR Das, BM Everett, KK Birtcher et al. -
SR-B1 Drives Endothelial Cell LDL Transcytosis via DOCK4 to Promote AtherosclerosisLZ Huang, KL Chambliss, PW Shaul et al.
-
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeuticsDI Swerdlow, DA Rider, A Yavari et al.
-
When, where, and how to target vascular inflammation in the post-CANTOS era?Maffia P, Guzik TJ.
-
Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)Budoff MJ, Young R, Burke G et al.
-
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of CardiologyDM Lloyd-Jones, LT Braun, CE Ndumele et al.
-
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?MS Madhur, F Elijovich, MR Alexander et al.
-
Association Between Depressive Symptoms and Incident Cardiovascular DiseasesEL Harshfield, L Pennells, Emerging Risk Factors Collaboration.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
